PRONULIFE®GasProtect/PRONULIFE®GasProtect-M

Booth No: J216

Characteristic

According to data from the Taiwan Cancer Foundation, there is a direct correlation between stomach ulcers and Helicobacter pylori (H. pylori). About 90% of patients with stomach ulcers have H. pylori in their stomachs, and approximately 30% of stomach cancer patients have H. pylori as well.

Glac's Development Center has developed PRONULIFE®GasProtect and PRONULIFE®GasProtect-M, probiotic ingredients for stomach health. These probiotic strains have been scientifically validated to provide comprehensive stomach health benefits, including helping to restore the balance of gut microbiota, resisting pathogenic microbial invasion, and inhibiting H. pylori infection.

【Patent】
I792249、I384990、CN102835666B、CN115137756B

Glac Biotech has established itself in the field of probiotics, leveraging decades of scientific research and big data platform analysis to continuously optimize probiotic manufacturing processes. By integrating modern gene chip technology, they developed the globally unique PRONEX® probiotic manufacturing technology. With world-leading probiotic production capabilities, they utilize professional expertise to extend product value and establish PRIMETEK® probiotic ODM technology.

【Read more】https://en.glac.com.tw/pronulife-stomach-health-probiotics